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A B S T R A C T
Aims: The secreted form of the α-Klotho gene (S-Klotho), which is considered a powerful biomarker of longevity,
makes it an attractive target as an anti-ageing therapy against functional decline, sarcopenic obesity, metabolic
and cardiovascular diseases, osteoporosis, and neurodegenerative disorders. The S-Klotho plasma levels could be
related to physical exercise inasmuch physical exercise is involved in physiological pathways that regulate the S-
Klotho plasma levels. FIT-AGEING will determine the effect of different training modalities on the S-Klotho
plasma levels (primary outcome) in sedentary healthy adults. FIT-AGEING will also investigate the physiological
consequences of activating the klotho gene (secondary outcomes).
Methods: FIT-AGEING will recruit 80 sedentary, healthy adults (50% women) aged 45–65 years old. Eligible
participants will be randomly assigned to a non-exercise group, i.e. the control group, (n=20), a physical
activity recommendation from World Health Organization group (n= 20), a high intensity interval training
group (n=20), and a whole-body electromyostimulation group (n=20). The laboratory measurements will be
taken at the baseline and 12 weeks later including the S-Klotho plasma levels, physical fitness (cardiorespiratory
fitness, muscular strength), body composition, basal metabolic rate, heart rate variability, maximal fat oxidation,
health blood biomarkers, free-living physical activity, sleep habits, reaction time, cognitive variables, and
health-related questionnaires. We will also obtain dietary habits data and cardiovascular disease risk factors.
1. Introduction
The global elderly population will dramatically increase by 2050
[1]. Despite the current rise in life expectancy, the increases in disease-
free years are higher, concentrating the prevalence of chronic diseases
in old age [2]. Age-related diseases, such as cardiovascular diseases,
osteoporosis, cancer and neurodegenerative disorders, represent the
major cause of morbidity and mortality in developed countries, with an
exponential growth of health costs [3,4]. However, significant inter-
individual variability exists in the health impact of ageing [5]. There-
fore, it is necessary to find strategies which can attenuate the ageing
process and improve the quality of life [6].
The α-Klotho gene encodes a type I single-pass transmembrane
protein of 1014 amino acid long, and it expresses itself in three
functionally different family members: the intra-cellular form which
binds sodium-potassium adenosine triphosphatase, the cell-membrane
form which forms a complex with fibroblast growth factor 23 and fi-
broblast growth factor receptor 1 and the secreted form (S-Klotho),
identified in blood, plasma, urine, and cerebrospinal fluid [7]. The S-
Klotho is considered a powerful biomarker of longevity [8] and has
several anti-ageing functions such as regulating the metabolism of
calcium and phosphate metabolism [avoiding cell's precipitation of
calcium phosphate and reducing apoptosis mechanism [8–11]], redu-
cing the inflammatory process [12] and the oxidative stress [13], and
protecting the oxidative stress cells, obtaining an anti-ageing effect
derived from these actions. Recent findings have discovered a pool of
novel α-Klotho gene activators such as Na+-dependent Pi cotransporter
type IIa (NaPi-IIa) and Na+-dependent Pi cotransporter type IIb (NaPi-
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IIb) [9–11], insulin, insulin-like growth factor-1 (IGF-1), transforming
growth factor beta (TGF-β), Wnt signaling pathway, and interferon
gamma (IFNγ) [14,15], and fibroblast growth factor 21 (FGF21) [16].
Physical fitness, which includes cardiorespiratory fitness [17,18]
and muscular strength [19], is an excellent predictor of both cardio-
vascular and all-cause mortality [20]. In addition, it is an important
predictor of living independently at older ages in both men and women
[21]. Moreover, it is well known that exercise improves physical fitness
in healthy [22] and unhealthy people [23], and it may also be effective
in preventing, delaying, or reversing the ageing effects on tissue health
and functioning [24].
Of interest is that several studies have reported that exercise induces
the activation of various factors that also increase the expression of the
α-Klotho gene [25,26]. Several studies have shown that a single bout of
exercise produces an S-Klotho plasma levels increase both in animal
models [27] and in humans [28,29]. Although Matsubara el al. (2014)
showed that aerobic exercise training increased the S-Klotho plasma
levels in postmenopausal women [30], little is known about which are
the chronic effects of different training modalities on the S-Klotho
plasma levels in sedentary healthy adults.
The overall objective and primary outcome of the FIT-AGEING
randomized controlled trial (RCT) is to quantify the effects of different
training modalities on the S-Klotho plasma levels in sedentary healthy
adults. The training modalities will be (i) no exercise, (ii) physical ac-
tivity recommendation from the World Health Organization, (iii) High
Intensity Interval Training, and (iv) Whole-Body Electromyostimulation
training. The secondary outcomes of this study will focus on the
quantification of the effects of the above-mentioned training modalities
on physical fitness components, body composition and anthropometric
measurements, energy expenditure and nutrients oxidation, heart rate
variability (HRV), health blood biomarkers, free-living physical ac-
tivity, cognitive variables, health-related quality of life, dietary habits,
and cardiovascular disease risk factors.
2. Methods
The present study is a RCT (ClinicalTrials.gov ID: NCT03334357)
approved by The Human Research Ethics Committee of the “Junta de
Andalucia” [0838-N-2017]. All participants will have to provide an
informed consent. The participants will be randomly allocated to a
control group, a physical activity recommendation group (PAR), high
intensity interval training group (HIIT), and whole-body electro-
myostimulation group (WB-EMS). All of the baseline and follow-up
examinations will be performed at the same setting [Instituto Mixto
Universitario Deporte y Salud (IMUDS) at the University of Granada].
The study will follow the revised ethical guidelines of the Declaration of
Helsinki.
2.1. Participants and selection criteria
The participants will be adults from the province of Granada
(Spain). Granada has ≈885,000 population, of which ≈190,000 are
adults aged 45–65. The eligible participants should be 45–65 years old,
and they must have a body mass index (BMI) between 18.5 and 35 kg/
m2. The inclusion and exclusion criteria are listed in Table 1. We
decided to conduct the intervention on overweight and obese adults
because overweight and obesity accelerate the ageing of adipose tissue,
increase the formation of reactive oxygen species in fat cells, shorten
telomeres, and produce the inhibition of the p53 tumor suppressor [31],
which are factors that could be related to the S-Klotho plasma levels.
Considering that aerobic exercise is able to increase the S-Klotho
plasma levels in normal-weight young and senior adults according to
literature [32], we will also include participants with a BMI between
18.5 and 24.9 kg/m2. Including people with different weight status and
body composition allows to study S-Klotho plasma levels differences
across different categories (i.e. normal-weight, overweight, and obese
based on BMI, and on body fat measures).
All participants will have a health history and a medical examina-
tion done prior to the intervention program to minimize risks by ruling
out contraindications to the testing and training protocols. If any par-
ticipant suffers any injury or medical problem, a medical evaluation
will be performed and, if necessary, they will be excluded from the
study.
The study will be announced on social networks, local media, and
posters at different points of Granada. We will also organize informa-
tion meetings at the School of Medicine of the University of Granada.
The people interested will be able to contact the research team by e-
mail and phone. Later, they will visit our facilities to receive a thorough
explanation about the study's aims, the test to be performed, the in-
clusion and exclusion criteria, and the types of intervention. What
participants can expect from the study will be clarified, and any ques-
tions will be answered. The potentially interested participants meeting
the inclusion criteria will be invited to a second orientation session; in
this case, the participants will receive detailed written information
about the study, and the informed consent. The participants will be
cited for their baseline measurement. Fig. 1 shows the participant flow
from the recruitment to the randomization stages.
2.2. Participants and selection criteria
After completing the baseline measurements, the selected partici-
pants will be randomly assigned to either the control or the exercise
training groups. The randomization will be computer-generated. We
will use simple randomization [33], hence disparities in group size and
in the number of men and women are possible. The assessment staff will
be blinded to the participant randomization assignment. The partici-
pants will be explicitly informed of their assigned group, as well as of
the study hypotheses. They will also be frequently reminded not to
disclose their randomization assignments to the assessment staff in the
follow-up measurements. For practical and feasibility reasons, the study
will be conducted in two waves (maximum 45 participants).
2.3. Sample size
The determination of the sample size and power of the study are
made based on the data of a pilot S-Klotho plasma levels sample [34].
We have considered S-Klotho plasma levels differences between pre and
post-treatment in order to assess the sample size requirements for the
one-way ANOVA [35]. As a result, we expect to detect an effect size of
100 pg/ml considering a type I error of 0.05 with a statistical power of
0.85 if we consider a minimum of 14 participants per group. Assuming
a maximum loss at follow-up of 25%, we decided to recruit 20 parti-
cipants (≈50% women) for each study group: control, PAR, HIIT, and
WB-EMS. A total of 80 participants (≈40 women and≈40 men) will be
enrolled in FIT-AGEING. Based on previous RCT and on our own ex-
perience [36,37], we think that the sample size is realistic and acces-
sible.
2.4. Statistical analysis
All outcome variables will be verified for normality, and the results
will be expressed as mean and SD. For between group comparisons at
the baseline (control group vs PAR vs HIIT vs WB-EMS), we will analyze
continuous variables with the one-way analysis of variance or the non-
parametric method of Kruskal–Wallis and Chi-square tests, as appro-
priate. We will use General Lineal Models to assess the training effects
[time (pre-post 3-month intervention)× group interactions] on the
primary and secondary study outcomes. We will adjust multiple com-
parisons for mass significance [38]. We will also examine the differ-
ences in the baseline measurements between the participants who re-
main in the study and the drop-outs. We will analyze the data according
to the intention-to-treat principle [39], and we will handle missing data
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resulting from drop-outs or non-compliance using multiple imputation
methods. To fully appreciate the potential influence of missing re-
sponses, we will perform sensitivity analyses to examine whether the
imputation method affects the outcomes. In addition, we will perform
multiple regression analyses to evaluate potential independent pre-
dictors of the α-Klotho protein concentration.
2.5. Participant retention and adherence
The participants will be allowed to withdraw at any time; however,
to reduce participants drop-out and to maintain adherence to the
training program, several strategies will be implemented. In anticipa-
tion of private commitments, vacations, etc., the intervention program
will be carried out from September to December. All sessions will be
accompanied by music, and will be held on an airy, well-lighted, and
well-equipped gym. Qualified and certificated trainers will carefully
supervise every training session, and they will work with groups of no
more than three persons to ensure that the participants will do the
exercises correctly, and at a correct intensity. The training specialist
and other study staff will constantly support the participants.
2.6. Exercise program rationale
Since there is no information regarding the ideal exercise model to
induce higher levels of the S-Klotho plasma levels, FIT-AGEING will
apply different exercise methods. These methods will be (i) PAR
[40–43], (ii) HIIT, and (iii) WB-EMS.
One of the most important aims of the study is to compare various
exercise intensity levels (moderate vs. high intensity) to test if higher
intensity levels provide more benefits despite the application of a lower
training volume.
The trial length will be twelve weeks based on (i) the results of a
previous study [30] and (ii) taking into account that the substantial
physiological adaptations occur within the first 3–6 months of exercise
[40]. We will provide no dietary prescriptions or instructions to the
participants in the control and exercise groups. The participants will be
asked to maintain their dietary habits during the intervention period.
2.6.1. PAR training
2.6.1.1. Volume. Given the importance of the transferability of results
to the general population in terms of time, intensity, and frequency, the
volume of PAR will be based on the minimum physical activity
recommended by the World Health Organization (150min/week at
moderate intensity).
2.6.1.2. Intensity. Physical activity at moderate intensity is
recommended to sedentary people by important health institutions to
obtain health benefits [41,42,44]. Physical activity at 60% of the heart
rate reserve produces significant physiological adaptations in sedentary
adults [41,42,44]. For this reason, the intensity selected for PAR
aerobic training is 60–65% of the heart rate reserve (HRres). One-
repetition maximum (1RM) is the maximum amount of force that can
be generated in one maximal contraction, and it is used to determine
the intensity of resistance training [45]. The World Health Organization
recommends an intensity of 40–50% of 1RM to improve muscle
strength, and to increase muscle mass in sedentary persons which
have never done strength training [43]. Therefore, the intensity
selected for this training modality is 40–50% of 1RM. We will also
consider other variables that influence strength training, such as
eccentric-isometric-concentric speed ratio, recovery time, and range
of motion [46].
2.6.1.3. Frequency. Considering several studies that have compared the
effects of different training frequencies on physical fitness as a health
Table 1
Selection criteria.
Inclusion criteria Exclusion criteria
Age: 45–65 years old History of cardiovascular disease
Body mass index: 18.5–35 kg/m2 Diabetes
Not engaged in regular physical activity> 20min on>3 day/week Pregnancy or planning to get pregnant during the study period
Not participating in a weight-loss program Beta blockers or benzodiazepines use
Stable weight over the last 5 months (body weight changes> 5 kg) Taking medication for thyroid
The participants must be capable and willing to provide consent, understand the exclusion
criteria, and accept the randomized group assignment
Other significant conditions that are life-threatening or that can interfere
with or be aggravated by exercise
Normal electrocardiogram Unwillingness to either complete the study requirements or to be randomized
into the control or training group
Fig. 1. Flow diagram of the study participants.
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marker, the World Health Organization recommends a dose of 3 or 4
days/week [44]. Because the lack of time is one of the most important
causes of participant dropout, we have determined that the PAR group
will train 3 days/week, the minimum frequency recommended.
Resistance training will be performed on 2 of these 3 days/week. In
addition, the participants will be advised to refrain from training for a
minimum of 24 h and ideally 48 h. The participants will be phoned if
they do not meet the weekly recommendations.
2.6.1.4. Type of exercise. The exercises programmed for the aerobic
training section will be treadmill, cycle-ergometer, and elliptical
ergometer. For the resistance training section, we will include weight-
bearing and guided pneumatic machines, involving the major upper
and lower body muscle groups [43].
2.6.1.5. Training load variation. We consider that participants may not
be immediately capable of meeting the volume and intensity dose
required. Therefore, we have proposed a gradual progression to control
the exercise dose (see Table 2) based on a previous RCT [37].
The participants will begin with an aerobic dose of 75min/week at
60%HRres. It will progressive increase 30min/week, and the partici-
pants will achieve 150min/week on the 4th week. Regarding resistance
training, the participants will perform a 2-week familiarization phase;
they will learn the movement patterns which are based on resistance
exercises of a specific training program (dead lift, squat, horizontal, and
vertical push-pull, etc.). In addition, the participants will do compen-
satory exercises to improve core competency and joints stabilization, in
order to avoid injuries.
It is well known that, as the fitness level of participants increases,
aerobic and strength load should be higher. Aerobic training intensity
will increase, since it is necessary to rise the previously established
intensity to maintain a specific percentage of HRres, when the physical
fitness is increased. In addition, we will measure the RM of all exercises
on the first week of each phase in order to adjust the resistance training
load. On the other hand, it is important to consider that the session
organization determines different physiological adaptations in terms of
muscle hypertrophy (metabolic stress, muscle damage etc.) [46]. Due to
the fact that the best training stimulus to induce higher levels of the S-
Klotho plasma levels is unknown, we will include different types of
sessions during each training phase.
2.6.1.6. Training periodization. The training periodization is shown in
Table 2. It is divided into two different phases, and its duration will be
of 5 weeks, starting with a familiarization phase. The training program
structure is based on other randomized controlled trials, which had the
aim to meet the physical activity recommendations for adults suggested
by World Health Organization [37,41].
FAMILIARIZATION PHASE: This phase will last two weeks. The
principal aim of this phase will be to learn the main movement patterns
(squat, hinge, bridge, and horizontal and vertical pulls and push) and to
improve many physical fitness components such as cardiorespiratory
fitness, core stability, joint stabilizing muscles, balance, and flexibility.
These sessions will prepare the participants for the 1RM evaluation.
PHASE 1: The participants will perform two combined sessions
(aerobic and resistance training) and only one aerobic training session
in phase 1. The aerobic training volume will be 150min/week (except
in RM weeks, with a duration of 120min/week) and the aerobic
training intensity will be 60%HRres in all cases. The resistance training
will include exercises involving the major muscle groups and principal
movement patterns (squat, bench press, dead lift, lateral pull down …)
and compensatory exercises.
Combined sessions will have type I structure (see Table 3) which
alternate 4 resistance exercises involving the major muscle groups, 2
core stability exercises, and 2 compensatory exercises with 10-min sets
of aerobic training.
PHASE 2: In this case, the combined sessions will be different in
order to provide a different resistance training stimulus [41,46,47]. The
combined session will be divided into type I session (which focuses on
mechanical tension and muscle damage) and type II session (which
focuses on metabolic stress) [46,47]. Both sessions will include similar
exercises to those reported in phase 1, as well as several exercises which
involve small muscle groups (lateral raises, French press, or lateral
raises).
2.6.1.7. Training sessions. The participants should complete a total of
60min of aerobic exercise in non-combined sessions (only aerobic
exercises). These sessions will start with a dynamic standardized warm-
up, including several muscle activation exercises. In addition, aerobic
sessions will include compensatory exercises.
All combined training sessions will begin like a non-combined ses-
sion. After the warm-up, an aerobic exercise will be carried out on 10-
min sets, alternating with resistance exercises (depending on the session
[see Table 3]). The participants will have the possibility to change the
ergometer in different 10-min aerobic sets (treadmill, elliptical, or
cycle-ergometer).
In all cases, the training session will end with a cooling-down pro-
tocol (active global stretching); the participants will complete 5 ante-
rior or posterior chain exercises.
2.6.2. HIIT training
HIIT describes physical exercise characterized by short and inter-
mittent efforts of vigorous activity, interspersed with resting periods at
Table 2
PAR training periodization.





Intensity (%RM) Type of exercise Training stimulus




Movement pattern Compensatory training
WEEK 2 105 60
PHASE I WEEK 3 120 60 RM ASSESTMENT
WEEK 4 150 60 50 Exercises involving major
muscle groups
Initial adaptations to resistance
training
Compensatory training
WEEK 5 150 60 50
WEEK 6 150 60 50
WEEK 7 150 60 50
PHASE II WEEK 8 120 60 RM ASSESTMENT
WEEK 9 150 60 50 Exercises involving major
muscle groups
Session type A: mechanical tension
and muscle damage
Session type B:
Metabolic StressWEEK 10 150 60 50
WEEK 11 150 60 50
WEEK 12 150 60 50
PAR: Physical Activity Recommendations for adults proposed by the World Health Organization, HRres: Heart Rate Reserve, RM: Repetition Maximum.
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passive or low-intensity exercises. There are many HIIT protocols, and
the specific physiological adaptations induced by this training modality
are related to exercise stimulus, (i.e. the intensity, duration, or number
of intervals performed), as well as the duration and activity patterns
during recovery [48,49]. The energy expenditure at HIIT (more in-
tensity and low volume) is the same (or even higher in some cases) as
moderate intensity exercise. However, HIIT physiological and health-
related markers are better in healthy and diseased populations [49–51].
These findings are important from a public health perspective, because
the ‘lack of time’ is one of the most common problems to do exercise.
2.6.2.1. Volume. The volume in HIIT (40–65min/week at high
intensity) will be smaller than the minimum physical activity
recommended by the World Health Organization (75min/week at
vigorous intensity).
2.6.2.2. Intensity. The HIIT intensity is based on scientific evidence
[48,49,52,53]. HIIT participants will perform two different
complementary protocols: (i) HIIT with long intervals (Type A
session), with an intensity of> 95% maximum oxygen uptake
(VO2max) and (ii) HIIT with short intervals (Type B session), with an
intensity of> 120% VO2max (> 90% HRres or< 9 Rating of
Perceived Exertion {0–10 RPE scale} [54]). The intensity will
progressively increase after the familiarization phase.
2.6.2.3. Frequency. Traditionally, HIIT has been recommended 3
times/week [52,53]. However, considering the age of the participants
(45–65 years old) and their training level (sedentary), we have decided
to reduce the training frequency (twice per week), since this population
needs a 72-h rest after a HIIT session [55].
2.6.2.4. Type of exercise. The exercises programmed for HIIT with long
intervals (type A session) are walking on the treadmill with
personalized slopes. For the HIIT with short intervals (type B session),
the participants will perform eight weight-bearing exercises in circuit
form, (i.e. squat, dead lift, high knees up, high heels up, push up,
horizontal row, lateral plank, and frontal plank).
2.6.2.5. Training load variation. We consider that participants will not
be immediately capable of meeting the volume and intensity dose
required; therefore, we propose a gradual progression to control the
exercise dose.
The participant will start with a dose of< 40min/week at
80%–90% VO2max in type A and type B sessions (HIIT familiarization
phase). It will progressive increase to 50min/week at> 95% in type A
session and 120% VO2 max in type B session (HIIT phase I) and to
65min/week at> 95% in type A session and 120% VO2 max in type B
session (HIIT phase II).
2.6.2.6. Training periodization. The training periodization is shown in
Table 4. It is divided into three phases: (1) HIIT familiarization phase,
(2) HIIT phase I, (3) HIIT phase II.
HIIT FAMILIARIZATION PHASE: This phase will last 4 weeks. The
participants will carry out 2 types of sessions each week, type A and
type B. The intensity selected for the first and the second week will be
80% VO2max. The intensity and the volume will be higher in the third
and fourth week. In session type A, the participants will complete 6–9
sets of 4min (2min work/2min rest) with a maximal duration of
18min/session. In session type B, the participants will complete 2 sets
(8–9.5 min) of 16 exercises (15–20 s work/15–20 s rest) with an active
rest of 5min at 60% VO2max and a maximal duration of 19min/ses-
sion.
HIIT PHASE I: The participants will do two different sessions as in
the familiarization phase. The intensity will be> 95%VO2max in type
A session, and>120%VO2max in type B session. The training volume
will be less than 50min/week. In session type A, the participants will
Table 3
Combined training session in the PAR training program.
Session Type I Session Type II
EXERCISE SETS VOLUME INTENSITY EXERCISE SETS VOLUME INTENSITY
WARM-UP WARM-UP
Aerobic Warm-up 1 5min 60% HRres Aerobic Warm-up 1 5min 60% HRres
Dynamic Warm-up 1 5min Dynamic Warm-up 1 5min
MAIN PART MAIN PART
Aerobic I 1 10min 60% HRres Aerobic I 1 10min 60% HRres
Resistance Exercise I 1 10 reps 40–50% RM Aerobic II 1 10min 60% HRres
Resistance Exercise II 1 10 reps 40–50% RM Resistance Exercise I 1 10 reps 40–50% RM
Resistance Exercise III 1 10 reps 40–50% RM Resistance Exercise V 1 10 reps 40–50% RM
Resistance Exercise IV 1 10 reps 40–50% RM Resistance Exercise II 1 10 reps 40–50% RM
Aerobic II 1 10min 60% HRres Resistance Exercise VI 1 10 reps 40–50% RM
Resistance Exercise I 1 10 reps 40–50% RM Resistance Exercise III 1 10 reps 40–50% RM
Resistance Exercise II 1 10 reps 40–50% RM Resistance Exercise VI 1 10 reps 40–50% RM
Resistance Exercise III 1 10 reps 40–50% RM Resistance Exercise IV 1 10 reps 40–50% RM
Resistance Exercise IV 1 10 reps 40–50% RM Resistance Exercise VIII 1 10 reps 40–50% RM
Aerobic III 1 10min 60% HRres Aerobic III 1 10min 60% HRres
Resistance Exercise I 1 10 reps 40–50% RM Aerobic IV 1 10min 60% HRres
Resistance Exercise II 1 10 reps 40–50% RM COOL-DOWN 1 5min
Resistance Exercise III 1 10 reps 40–50% RM
Resistance Exercise IV 1 10 reps 40–50% RM
Aerobic IV 1 10min 60% HRres
Resistance Exercise I 1 10 reps 40–50% RM
Resistance Exercise II 1 10 reps 40–50% RM
Resistance Exercise III 1 10 reps 40–50% RM
Resistance Exercise IV 1 10 reps 40–50% RM
COOL-DOWN 1 5min
PAR: Physical Activity Recommendations for adults proposed by the World Health Organization, HRres: Heart Rate Reserve, RM: Repetition Maximum, Reps:
Repetitions, Min: minutes.
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complete 8–10 sets of 4min (2min work/2min rest) with a maximal
duration of 20min/session. In session type B, the participants will
complete 2 sets (8–12.5 min of duration) of 16 exercises (15–30 s work/
15–30 s rest) with an active rest of 5min at 60% VO2max and a max-
imal duration of 25min/session.
HIIT PHASE II: Sessions will follow the same structure than HIIT
PHASE I. However, training volume will be more than 50min/week but
less than 65min/week. In session type A, the participants will complete
6–8 sets of 5min (3min work/2min rest) with a maximal duration of
24min/session (intensity> 95% VO2max). In session type B, the par-
ticipants will complete 3 sets (8–12.5min duration) of 16 exercises
(15–30 s work/15–30 s rest) with an active rest of 5min–60% VO2max
and a maximal duration of 37min/session (intensity> 120%
VO2max). The exercises in session type B can be modified in order to
increase their difficulty (add external load, increase range of motion,
add instability, etc.) because it will be expected that physical fitness
increases as a training adaptation.
2.6.2.7. Training sessions. Type A session: It will start with a dynamic
standardized warm-up, including several muscle activation exercises
followed by 5min of aerobic exercise on the treadmill at 60% VO2max.
After the warm-up, the participants will complete several treadmill sets
following the established parameters previously described.
Type B session: It will start with a dynamic standardized warm-up.
The participants will perform eight weight-bearing exercises (in circuit
form) twice per set with an active rest (walking at 60%VO2max)
following the periodization previously established.
In all cases, the training session will end with the same cooling-
down protocol described in PAR.
2.6.3. WB-EMS training
WB-EMS is becoming increasingly popular as a novel training
technology. WB-EMS is able to simultaneously stimulate up to 14–18
regions or 8–12 different muscle groups with up to 2.800 cm2 electrode
area [56]. Very few studies have determined the influence of WB-EMS
on ageing, physical fitness, body composition, and physiological para-
meters in sedentary healthy adults [57–59], and its effects are con-
troversial [60,61]. Therefore, it is essential to follow the scientific re-
commendations related to WB-EMS to avoid possible health problems
[62,63] produced by the irresponsible use of this technology
[58,59,63].
The WB-EMS training program will follow the same structure as the
HIIT intervention in terms of volume, intensity, frequency, type of ex-
ercise, training load variation, training periodization, and training
session. However, electrical impulses will be included in order to assess
whether the WB-EMS training will produce an extra effect compared
with the HIIT program.
2.6.3.1. Electrical parameters. Given that the participants have never
done WB-EMS, we decided to establish a progressive and gradual WB-
EMS training periodization in order to avoid possible dangerous health




Week 1 2 3 4
Session (type) 1 (A) 2 (B) 3 (A) 4 (B) 5 (A) 6 (B) 7 (A) 8 (B)
Exercises 1 (Tr) 8× 2=16 (W-B) 1 (Tr) 8× 2=16 (W-B) 1 (Tr) 8×2=16 (W-B) 1 (Tr) 8× 2=16 (W-B)
Volume 12min 16min 14min 21min 16min 16min 18min 21min
Intensity 80%VO2m 80%VO2m 80%VO2m 80%VO2m 90%VO2m 90%VO2m 90%VO2m 90%VO2m
Sets 6 2 7 2 8 2 9 2
Set duration 4min 8min 4min 10.5 min 4min 8min 4min 10.5min
Work exercise 2 min 15 Sec 2min 20 Sec 2min 15 Sec 2min 20 Sec
Rest exercise 2 min (pass) 15 Sec 2min (pass) 20 Sec 2min (pass) 15 Sec 2min (pass) 20 Sec
Rest between sets – 5min (60% VO2m) – 5min (60% VO2m) – 5min (60% VO2m) – 5min (60% VO2m)
HIIT PHASE I
Week 5 6 7 8
Session (type) 9 (A) 10 (B) 11 (A) 12 (B) 13 (A) 14 (B) 15 (A) 16 (B)
Exercises 1 (Tr) 8× 2=16 (W-B) 1 (Tr) 8× 2=16 (W-B) 1 (Tr) 8×2=16 (W-B) 1 (Tr) 8× 2=16 (W-B)
Volume 16min 16min 18min 21min 20min 27min 20min 32min







Sets 8 2 9 2 10 2 10 2
Set duration 4min 8min 4min 10.5 min 4min 13.5 min 4min 16min
Work exercise 2 min 15 Sec 2min 20 Sec 2min 25 Sec 2min 30 Sec
Rest exercise 2 min (pass) 15 Sec 2min (pass) 20 Sec 2min (pass) 25 Sec 2min (pass) 30 Sec
Rest between sets – 5min (60% VO2m) – 5min (60% VO2m) – 5min (60% VO2m) – 5min (60% VO2m)
HIIT PHASE II
Week 9 10 11 12
Session (type) 17 (A) 18 (B) 19 (A) 20 (B) 21 (A) 22 (B) 23 (A) 24 (B)
Exercises 1 (Tr) 8× 2=16 (W-B) 1 (Tr) 8× 2=16 (W-B) 1 (Tr) 8×2=16 (W-B) 1 (Tr) 8× 2=16 (W-B)










Sets 6 3 7 3 8 3 8 3
Set duration 4min 8min 4min 10.5 min 4min 13.5 min 4min 13.5min
Work exercise 3 min 15 Sec 3min 20 Sec 3min 25 Sec 3min 25 Sec
Rest exercise 2 min (pass) 15 Sec 2min (pass) 20 Sec 2min (pass) 25 Sec 2min (pass) 25 Sec
Rest between sets – 5min (60% VO2m) – 5min (60% VO2m) – 5min (60% VO2m) – 5min (60% VO2m)
Type A; High Intensity Interval Training on the treadmill with individual slopes, Type B; High Intensity Interval Power Training (weight-bearing exercises), Tr;
Treadmill, W-B; Weight-Bearing exercises, VO2m; Maximum oxygen uptake, Min; minutes, Sec; seconds, Pas; Passive.
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rhabdomyolysis [60,61].
The electrical parameters progression is shown in Table 5. Using the
WB-EMS devices from Wiemspro® (Malaga, Spain), bipolar, symme-
trical, and rectangular electric pulse will be applied. The periodization
of electric parameters can be seen in Table 5.
The typical frequency used in WB-EMS studies has been 85 Hz
[56–59,63]. However, our participants will be sedentary adults aged
45–65, and it has been shown that ageing is associated with a muscle
mass decrease, especially type II fibers, and this decrease in muscle
tissue begins around the age of 50 and dramatically increases beyond
the age of 60 [64,65]. In addition, it is well-known that the ideal fre-
quency to recruit type I fibers is 7–33 Hz [66]. Therefore, we will apply
a frequency of 15–33 Hz in our type A session (aerobic exercise). On the
other hand, we will apply a frequency of 35–75 Hz in the type B session
(resistance exercises) because, in this case, it will be active type II fibers
and the optimal frequency is 35–100 Hz [66].
INTENSITY: The intensity applied in our intervention program will
be 80–100mA, following the scientific guidelines established in local
electrostimulation in order to improve fitness and body composition
(> 50mA) [66]. The impulse intensity was individually adapted in
accordance with the participants in order to generate similar values of
rate of perceived exertion (RPE) than other WB-EMS studies (49,
54–59) using the Borg CR-10 Scale “5” of “9” [67].
IMPULSE WIDTH: The scientific recommendations regarding this
matter range between 200 and 400 μsec. We adjusted this parameter in
relation to the body segment: thigh zone (400 μsec), glute zone
(350 μsec), abdominal zone (300 μsec), dorsal zone (250 μsec), cervical
(200 μsec), chest zone (200 μsec), and arm zone (200 μsec) [66].
DUTY CYCLE: The stimulation ratio (duty cycle) is defined as ratio
of on-time to the total cycle time (% duty cycle= 100/[total time/on-
time]). A duty cycle of 50–70% will be used [57–59,68]. We have
programmed a duty cycle of 50–67% in type B (resistance training)
session following scientific evidence, but duty cycle in type A session
(aerobic exercise) will be 99% because the frequency will be low and
the work time will be of 3min maximum.
2.7. Control group
We will provide general advice to the control group participants
though an information meeting presided by a graduate in Sport
Sciences. They will be instructed to maintain their lifestyle.
2.8. Outcome variables
The primary outcome of our study is the S-Klotho plasma levels. The
secondary outcome variables include physical fitness components, body
composition and anthropometric measurements, energy expenditure
and nutrients oxidation, heart rate variability (HRV), health blood
biomarkers, free-living physical activity, cognitive variables, health-
related quality of life, dietary habits, and cardiovascular disease risk
factors (secondary outcomes) in sedentary healthy adults.
The baseline measurement will be organized on 4 days:
Day 1: Medical examination (anamnesis, blood pressure assessment
…) and fasting blood measurements.
Day 2: HRV during 15min, basal metabolic rate measure by indirect
calorimetry during 30min, body composition by Dual Energy X-ray
Absorptiometry scan (DXA) and anthropometric measurements, and
maximal fat oxidation during an incremental treadmill protocol
with a gas analyzer. All tests will be conducted under fasting con-
ditions.
Day 3: Isokinetic dynamometry strength test, cognition test and a
questionnaire battery test which includes the ALPHA –
Questionnaire Environment Perception, the Beck Depression
Inventory (BDI-II), the Sedentary Behavior, the Physical Activity
Attitude Questionnaire (C-AAF), Par-Q & You, the Health
Questionnaire SF-36, the Socio-demographic data, the HOPE as-
sessment, the Physical Fitness Condition Scale-International (IFIS),
the Pittsburgh Sleep quality, the Revised Life Orientation Test
(LOTR), the Satisfaction With Life Scale (SWLS), the Trait-Meta
Mood Scale (TMMS-24), the Positive and Negative Affect Schedule
(PANAS), PREDIMED questionnaire, and the Sexual Desire
Questionnaire.
Table 5
Electrical parameters in the WB-EMS training periodization.
FAMILIARIZATION PHASE
Week 1 2 3 4
Session (type) 1 (A) 2 (B) 3 (A) 4 (B) 5 (A) 6 (B) 7 (A) 8 (B)
Frequency 15 Hz 35 Hz 15 Hz 35 Hz 15 Hz 40 Hz 15 Hz 40 Hz
Intensity 100mA 80mA 100mA 80mA 100mA 80mA 100mA 80mA
RPE impulse (0–10) 5–6 5–6 6–7 6–7 7–8 7–8 7–8 7–8
Duty cycle 99% (59¨:1¨) 50% (15¨:15¨) 99% (59¨:1¨) 57% (20¨:15¨) 99% (59¨:1¨) 50% (15¨:15¨) 99% (59¨:1¨) 57% (20¨:15¨)
HIIT PHASE I
Week 5 6 7 8
Session (type) 9 (A) 10 (B) 11 (A) 12 (B) 13 (A) 14 (B) 15 (A) 16 (B)
Frequency 20 Hz 45 Hz 20 Hz 45 Hz 20 Hz 50 Hz 20 Hz 55 Hz
Intensity 100mA 80mA 100mA 80mA 100mA 80mA 100mA 80mA
RPE impulse (0–10) 7–8 7–8 7–8 7–8 7–8 7–8 7–8 7–8
Duty cycle 99% (59¨:1¨) 50% (15¨:15¨) 99% (59¨:1¨) 57% (20¨:15¨) 99% (59¨:1¨) 63% (25¨:15¨) 99% (59¨:1¨) 67% (30¨:15¨)
HIIT PHASE II
Week 9 10 11 12
Session (type) 17 (A) 18 (B) 19 (A) 20 (B) 21 (A) 22 (B) 23 (A) 24 (B)
Frequency 25 Hz 60 Hz 20 Hz 65 Hz 20 Hz 70 Hz 20 Hz 75 Hz
Intensity 100mA 80mA 100mA 80mA 100mA 80mA 100mA 80mA
RPE impulse (0–10) 8–9 8–9 8–9 8–9 8–9 8–9 8–9 8–9
Duty cycle 99% (59¨:1¨) 50% (15¨:15¨) 99% (59¨:1¨) 57% (20¨:15¨) 99% (59¨:1¨) 63% (25¨:15¨) 99% (59¨:1¨) 63% (25¨:15¨)
Type A; High Intensity Interval Training on the treadmill with individual slopes, Type B; High Intensity Interval Power Training (weight-bearing exercises), Hz; Hertz,
mA; milliamps.
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Day 4: Muscle strength test (manual isometric dynamometry and
core resistance stability), simple and discriminative reaction test and
maximum exercise test on a treadmill (h/p cosmos, Italy) with a gas
analyzer, electrocardiogram, and blood pressure control. All tests
will be supervised by a graduate in sport sciences, and a sport
medicine doctor.
We will use accelerometers to objectively measure physical activity,
sleep quality, and sleep volume. Finally, we will control the dietary
intake by three 24 h recalls and by a food frequency questionnaire.
2.8.1. Primary outcome: S-Klotho plasma levels
We will collect blood samples from the antecubital vein after 12 h of
fasting. The S-Klotho plasma levels will be measured by ELISA using a
soluble α-klotho ELISA assay kit (Demeditec, Kiel, Germany). The kit is
a non-competitive solid-phase sandwich ELISA that uses two types of
highly specific antibodies (purified mouse anti-human Klotho IgG). The
optical density is measured at a wavelength of 450 nm ± 2 nm and a
standard curve is generated using known antigen concentrations. All
participants will be requested to abstain from drugs and/or caffeine, to
eat a standardized dinner before sampling, and to avoid any physical
activity of moderate intensity (24 h before) and/or vigorous intensity
(48 h before).
We will also measure ageing markers such as a general biochemical
profile, red cells profile, immunological blood profile, brain-derived
neurotrophic factor, IGF-1, insulin, growth hormone, testosterone, free-
testosterone, cortisol, dehydroepiandrosterone, and D hormone. The
ELISA kits and spectrophotometry will be utilized to perform these
analyses.
2.8.2. Secondary outcome
2.8.2.1. Physical fitness. Cardiorespiratory fitness will be measured
through a maximum treadmill test (h/p cosmos, Italy) applying the
modified Balke protocol [69], which has been widely used and
validated [37,70–72]. We will also measure the O2 uptake and CO2
production with the breath by breath gas analyzer (CPX Ultima
CardiO2, Medical Graphics Corp, St Paul, USA) calibrated with
known gas mixtures and environmental air immediately before the
test. Consistently across each trial, the participants will be strongly
encouraged to invest maximum effort. The criteria for achieving
VO2max will be respiratory exchange ratio ≥1.1, a plateau in VO2
(change of< 100ml/min in the last three consecutive 10 s stage), and a
heart rate within 10 beats/min of the age-predicted maximal heart rate
(208–0.7∗age) [73]. We will include a second and constant work rate
test performed at 110% of the work rate achieved after the modified
Balke protocol test to resolve the classic V̇O2-work rate plateau, which
is the unambiguous validation of VO2max [74]. The exercise
electrocardiogram will be continuously monitored.
We will conduct isokinetic strength tests using a Gymnex Iso-2 dy-
namometer (EASYTECH s.r.l., Italy), calibrated following the product
instructions before the data collection. The knee extensor muscles will
be tested concentrically and eccentrically at 180° and 60° s-1. The upper
members, hips, and shoulders will be stabilized with safety belts. The
rotational axis of the dynamometer will be aligned with the right lateral
femoral condyle. The force pad will be placed 3–4 cm above the medial
malleolus. The knee extension will start with a 90º-joint angle and it
will end at 170°. The subject will be instructed to sub maximally flex
and extend the knee five times, and then complete three maximal re-
petitions. We will allow the participants a 1-min rest between sub-
maximal and maximal trials, and 5min between 180° and 60° s-1, fol-
lowing a scientific validated protocol [75]. The peak torque will be
determined as the single repetition with the highest muscular force
output (Nm). The participants will be encouraged by the trainer during
the test, and the same trainer-researcher will conduct all the isokinetic
testings.
We will measure the handgrip strength using a digital dynamometer
(TKK 5101 Grip-D; Takey, Tokyo, Japan). It will be measured following
the procedures described elsewhere [76].
We will evaluate the core resistance stability using a standard pro-
tocol described by McGill et al. [77], which has been extensively used
in scientific studies [78,79]. This methodology includes the Biering-
Sorensen extensor endurance test, flexor endurance test (60°), frontal
plank test, and the side bridge test.
2.8.2.2. Body composition and anthropometric measurements. The body
weight, height, hip circumference, and waist circumference will be
determined following the recommended standardization procedures
from the International Society for the Advancement of
Kinanthropometry (ISAK). We will also evaluate the fat mass, fat free
mass, lean body mass, visceral adipose tissue, and bone mineral density
by conducting a DXA scan (HOLOGIC, Wi).
2.8.2.3. Energy expenditure and nutrients oxidation. We will evaluate the
basal metabolic rate by indirect calorimetry with a breath by breath gas
analyzer (CPX Ultima CardiO2, Medical Graphics Corp, St Paul, USA).
The participants will be requested to attend the center in the post-
absorptive condition (12–14 h fasting), abstain from drugs and/or
caffeine, eat an established dinner before sampling, avoid physical
activity of moderate intensity (24 h before) and/or vigorous intensity
(48 h before). They will lie down on a bed, in a quiet environment.
Calorimetric measures will follow the scientific accepted standard to
ensure the validity of the tests [80,81].
A standardized treadmill protocol test will be used to measure
maximal fat oxidation [82]. More specifically, the test will start at
3.5 km h−1 and at a gradient of 0% during 3 min. The speed will then
increase until reaching the maximal speed that the participant can
comfortably maintain without running. The grade will increase by 2%
every 3 min until a respiratory quotient of 1 is reached. After that, the
speed will decrease until 4 km*h −1, and the grade will be 0% during
5min (active recovery). The respiratory gas measurements will con-
tinuously be collected using a metabolic cart (CPX Ultima CardiO2,
Medical Graphics Corp, St Paul, USA). Furthermore, the heart rate and
rating of the perceived exertion (RPE) record will be measured
throughout the whole test.
2.8.2.4. Heart rate variability (HRV). The assessment of HRV will be
carried out in a supine position before the basal metabolic rate test.
Polar RS800CX (Polar Electro, Kempele, Finland) will be used to
evaluate this parameter (R-R series active). The participants will be
informed that their heart activity will be recorded during 10min, and
they will be instructed not to talk or move excessively, and to relax as
much as possible. The participants will be in a supine position during
5min prior to the start of the recording. We will use the Kubios HRV
software (University of Eastern Finland, Kuopio, Finland) to process the
HRV [83].
2.8.2.5. Physical activity. The amount of physical activity and sleep will
be measured by accelerometry (ActiSleep, Actigraph, Pensacola,
Florida, USA). The participants will wear two accelerometers (non-
dominant wrist and right hip) during 7 consecutive days for 24 h to
assess physical activity volume and intensity and sleep quantity and
quality.
2.8.2.6. Cognitive performance and reaction time. Cognitive
deterioration is one of the most apprehensive aspects of ageing, and
it has been shown that exercise contributes to maintaining cognitive
and brain function [84]. We will evaluate cognitive functions through
simple and discriminative reaction time (Vienna Test System, Moedling,
Austria) and the Wechsler Adult Intelligence Scale test battery (WAIS-
III), which has been applied in several scientific studies [85].
2.8.2.7. Dietary assessment. We will conduct a dietary assessment at the
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baseline and after the intervention. Three 24-h dietary recalls (1 during
the weekend). We will also administer the participants a food frequency
questionnaire. All data will be processed by the dietetic software
EVALFINUT® (Ibero-American Foundation of Nutrition, Spain).
3. Potential impact of FIT-AGEING
‘Health, demographic change, and wellbeing’ is one of the main
challenges of Horizon 2020. FIT-AGEING contributes to the improve-
ment of our understanding of the causes and mechanisms underlying
health, healthy ageing, and disease, which is the principal topic that
Research & Innovation has supported (€2 billion). Previous studies have
shown that health disabilities (diabetes, osteoporosis, sarcopenic obe-
sity, etc.) could be attributed exclusively to age [86–88].
The expression of the α-Klotho gene is positively correlated with a
longer life spam, and the lack of the α-Klotho gene expression is related
to ageing phenotypes such as artheriosclerosis, decreased bone mineral
density, sarcopenia, skin atrophy, and impaired cognition [89]. Similar
anti-ageing effects have also been ascribed to exercise and physical
activity [20]. Therefore, the α-Klotho and physical activity are factors
that may promote upgrading capacities of the elderly and their relation
has been shown in scientific studies [32]. However, the mechanism that
may mediate these effects is currently unknown.
FIT-AGEING will study the effect of different exercise modalities on
the S-Klotho plasma levels during 3 months (our principal outcome) for
the first time in humans. In addition, FIT-AGEING will also measure
other important health-related variables that may be related to the
ageing process. Our study integrates physiology, biochemical para-
meters, and preventive medicine in order to investigate how physical
exercise can induce an increase of the S-Klotho plasma levels in adults.
The findings from FIT-AGEING could be significant implications for
our understanding of exercise and its protective effects against the
ageing process and ageing-related diseases.
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